Intel Receives FDA Market Clearance on In-Home Medical Device for Management of Health Conditions

	Intel Receives FDA Market Clearance on In-Home...

SANTA CLARA, Calif., July 10, 2008 – Intel Corporation today announced the receipt of 510(k) market clearance from the U.S. Food and Drug Administration (FDA) on Intel's personal health system, the Intel® Health Guide, a care management tool for healthcare professionals who manage patients with chronic conditions.

- View Press Release
- Visit Intel Corporation

Posted: July 10, 2008 | By: Wissen Schwamm

Recent Intel-Press related news.

Intel Takes Next Step Toward Building Scalable Silicon-Based Quantum Processors

More than 500 AI Models Run Optimized on Intel Core Ultra Processors

Intel Reports First-Quarter 2024 Financial Results

Intel Builds World’s Largest Neuromorphic System to Enable More Sustainable AI

Intel Brings AI-Platform Innovation to Life at the Olympic Games

+ View more Intel-Press related news +

			More Technical Information Than You Can Handle.

Intel Receives FDA Market Clearance on In-Home...